About Glimepiride And Metformin Hydrochloride Extended Release Tablets IP
Glimepiride and Metformin Hydrochloride Extended Release Tablets IP combine two active salts, Glimepiride (1mg) and Metformin Hydrochloride (500mg), designed to support blood sugar management in adults with type 2 diabetes. With its extended-release design, this medication ensures consistent and effective release of active components for optimal results throughout the day. These tablets are presented in a convenient physical form, making them easy to administer. Packaged in quantities of 10*10 pieces, they are suitable for storage at room temperature and hold their efficacy when maintained properly. This blend of salts offers dual benefits: Glimepiride stimulates insulin secretion, while Metformin helps reduce glucose production and absorption. Ideal for adult patients, this prescription medication serves as a trusted solution in diabetes care.
FAQs of Glimepiride And Metformin Hydrochloride Extended Release Tablets IP:
Q: What is the primary use of Glimepiride and Metformin Hydrochloride Extended Release Tablets IP?
A: These tablets are primarily used to manage blood sugar levels in adults with type 2 diabetes.
Q: How should this product be stored?
A: It should be stored at room temperature to maintain its efficacy.
Q: What is the salt composition in these tablets?
A: Each tablet contains Glimepiride 1mg and Metformin Hydrochloride 500mg.
Q: Is this medication suitable for children?
A: No, it is specifically designed for adult patients only.
Q: In what quantity are these tablets available?
A: They are available in packs of 10*10 pieces.